These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 25766591

  • 1. Regional diffusion of botulinum toxin in facial muscles: a randomised double-blind study and a consideration for clinical studies with split-face design.
    Punga AR, Eriksson A, Alimohammadi M.
    Acta Derm Venereol; 2015 Nov; 95(8):948-51. PubMed ID: 25766591
    [Abstract] [Full Text] [Related]

  • 2. Correlation of botulinum toxin dose with neurophysiological parameters of efficacy and safety in the glabellar muscles: a double-blind, placebo-controlled, randomized study.
    Alimohammadi M, Andersson M, Punga AR.
    Acta Derm Venereol; 2014 Jan; 94(1):32-7. PubMed ID: 23975053
    [Abstract] [Full Text] [Related]

  • 3. Understanding the functional anatomy of the frontalis and glabellar complex for optimal aesthetic botulinum toxin type A therapy.
    Lorenc ZP, Smith S, Nestor M, Nelson D, Moradi A.
    Aesthetic Plast Surg; 2013 Oct; 37(5):975-83. PubMed ID: 23846022
    [Abstract] [Full Text] [Related]

  • 4. Electromyographic differences between normal upper and lower facial muscles and the influence of onabotulinum toxin a.
    Winn BJ, Sires BS.
    JAMA Facial Plast Surg; 2013 May; 15(3):211-7. PubMed ID: 23430072
    [Abstract] [Full Text] [Related]

  • 5. The Frontalis Activity Measurement Standard: a novel contralateral method for assessing botulinum neurotoxin type-A activity.
    Nestor MS, Ablon GR.
    J Drugs Dermatol; 2011 Sep; 10(9):968-72. PubMed ID: 22052264
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The efficacy of intradermal injection of type A botulinum toxin for facial rejuvenation.
    Zhu J, Ji X, Xu Y, Liu J, Miao YY, Zhang JA, Luo D, Zhou BR.
    Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27862727
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The use of botulinum toxin type A in cosmetic facial procedures.
    Jaspers GW, Pijpe J, Jansma J.
    Int J Oral Maxillofac Surg; 2011 Feb; 40(2):127-33. PubMed ID: 20965695
    [Abstract] [Full Text] [Related]

  • 15. Does Linear or Spot Injection Technique Matter in Upper Face Botulinum Toxin Type A Application? A Split-Face Randomized Trial.
    Li Y, Sun Y, Lan X, Wu T, Xiao Y, Xia Z, Wang HC, Yu N, Wang X, Long X.
    Plast Reconstr Surg; 2024 Oct 01; 154(4):656e-665e. PubMed ID: 37184512
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of diffusion and duration of action of a new botulinum toxin type A formulation.
    Stone HF, Zhu Z, Thach TQ, Ruegg CL.
    Toxicon; 2011 Aug 01; 58(2):159-67. PubMed ID: 21658400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.